|

Chimeric antigen receptor T cells Clinical Trials

2 actively recruiting trials across 1 location

Also known as: CAR T Cell, CAR T Cells, CAR T-cells, CAR-T, CAR-T Cell +3 more

Pipeline

Phase 1: 2

Top Sponsors

  • Zhujiang Hospital1
  • City of Hope Medical Center1

Indications

  • Cancer2
  • Leukemia, Acute Myelogenous (AML)1
  • Leukemia, Acute Lymphocytic (ALL)1
  • Platinum-Resistant Ovarian Carcinoma1
  • Myelodysplastic Syndromes1

Other1 trial

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS
Phase 1

Duarte, California1 trial

Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer

City of Hope Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.